Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Resch

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
European Radiology|December 2, 2020
Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?Nicolai Alexander Huebner, Stephan Korn, Irene Resch, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 18, 2016
Anxiety and depression analyses of patients undergoing diagnostic cystoscopyStephan Seklehner, Paul Friedrich Engelhardt, Mesut Remzi, et al.
European Urology Focus|February 25, 2020
Adherence to European Association of Urology and National Comprehensive Cancer Network Guidelines Criteria for Inguinal and Pelvic Lymph Node Dissection in Penile Cancer Patients-A Survey Assessment in German-speaking Countries on Behalf of the European Prospective Penile Cancer Study GroupRodrigo Suarez-Ibarrola, Friedemann Zengerling, Marlene Haccius, et al.
Urologic Oncology|August 17, 2021
Adjuvant therapy with tyrosine kinase inhibitors for localized and locally advanced renal cell carcinoma: an updated systematic review and meta-analysisEkaterina Laukhtina, Fahad Quhal, Keiichiro Mori, et al.
Critical Reviews in Oncology/Hematology|December 13, 2021
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomesEkaterina Laukhtina, Reza Sari Motlagh, Keiichiro Mori, et al.
World Journal of Urology|August 1, 2023
Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancerKatharina Rebhan, Philipp D Stelzer, Benjamin Pradere, et al.
Annals of Surgical Oncology|March 29, 2022
Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical CystectomyKeiichiro Mori, Victor M Schuettfort, Satoshi Katayama, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2021
Prognostic role of the systemic immune-inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaborationKeiichiro Mori, Irene Resch, Noriyoshi Miura, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
European Radiology|December 2, 2020
Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?Nicolai Alexander Huebner, Stephan Korn, Irene Resch, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 18, 2016
Anxiety and depression analyses of patients undergoing diagnostic cystoscopyStephan Seklehner, Paul Friedrich Engelhardt, Mesut Remzi, et al.
European Urology Focus|February 25, 2020
Adherence to European Association of Urology and National Comprehensive Cancer Network Guidelines Criteria for Inguinal and Pelvic Lymph Node Dissection in Penile Cancer Patients-A Survey Assessment in German-speaking Countries on Behalf of the European Prospective Penile Cancer Study GroupRodrigo Suarez-Ibarrola, Friedemann Zengerling, Marlene Haccius, et al.
Urologic Oncology|August 17, 2021
Adjuvant therapy with tyrosine kinase inhibitors for localized and locally advanced renal cell carcinoma: an updated systematic review and meta-analysisEkaterina Laukhtina, Fahad Quhal, Keiichiro Mori, et al.
Critical Reviews in Oncology/Hematology|December 13, 2021
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomesEkaterina Laukhtina, Reza Sari Motlagh, Keiichiro Mori, et al.
World Journal of Urology|August 1, 2023
Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancerKatharina Rebhan, Philipp D Stelzer, Benjamin Pradere, et al.
Annals of Surgical Oncology|March 29, 2022
Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical CystectomyKeiichiro Mori, Victor M Schuettfort, Satoshi Katayama, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2021
Prognostic role of the systemic immune-inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaborationKeiichiro Mori, Irene Resch, Noriyoshi Miura, et al.
Pageof 3